The short version
Found is a membership-plus-medication telehealth provider. As of the September 12, 2026 build, for tirzepatide its lowest 12-month all-in total is $4,686 (month-to-month plan, reported), which places it 32 of 34 ranked telehealth providers. Verification status: reported.
The numbers, plan by plan
- Semaglutide (standard, month-to-month plan): no rankable price. "From $99" compounded GLP-1 treatment plus membership/program options from $49; not a standard recurring all-in price.
- Tirzepatide (standard, injection, month-to-month plan): $359 per month after an introductory $149 per month for the first 1 month. Status: reported, checked August 2, 2026. $149 for the first month is supported by Found's store page; the $359 renewal figure comes from a third-party directory (checked August 2, 2026) and was not found on an authoritative checkout page. Membership from $49 per month is billed separately.
Fees and what the price includes
A membership or program fee of $49 per month is billed on top of the medication, so the advertised medication price is not the monthly total. Shipping is billed separately. The clinician consultation is included. The price does not change with dose.
How this pricing structure plays out over a year
The first 1 month costs $198 all-in; from month 2 the recurring cost is $408 a month, so the advertised $149 covers 4% of the first year's spend and the recurring price covers the rest. The price does not move with dose, which removes the largest hidden cost in this market; a patient at 15 mg pays what a patient at 2.5 mg pays. The $49 membership is billed whether or not medication ships that month, which is the structure to read most carefully before a pause or a dose hold.
Compared with the field
On tirzepatide, Found's lowest twelve-month total of $4,686 is $3,258 above the lowest (SnagRx, $1,428) and above the median of $2,946 across 34 ranked providers, placing it 32 of 34. On the value score it scores 58 against 91 for NexLife, the best-scoring provider; the gap comes from cost, transparency, care, verification.
Pharmacy, coverage and cancellation
The provider reports serving all fifty states. Dispensing: 503A (provider-stated; pharmacy not named). Commitment: month-to-month membership. Cancellation: Cancel anytime.
Questions to ask Found before paying
Ask, in writing: Which pharmacy fills the prescription, is it 503A or 503B, and can I see a certificate of analysis for my batch? What is the price from month two, and does it change at renewal? Will my dosing instructions state the concentration of the vial you actually ship, and will you reissue them if it changes? A provider that answers all of these promptly is operating in the open; one that will not name its pharmacy has answered the most important question.
What works
Broad medication menu including brand-name and non-GLP-1 options. Coaching and behavior-change program included. Insurance support for brand medication.
What to weigh against it
Membership is separate from medication, so the advertised price understates the monthly total. Medication pricing pending verification.
Who should choose Found
Patients who want a coaching-heavy program and may qualify for insurance-covered brand medication. A patient with insurance coverage for Zepbound or Wegovy should compare the copay route first; a patient who wants a verified flat all-in price with month-to-month flexibility should compare the best overall provider on our value score; and any patient should ask which pharmacy fills the prescription before paying.
Is Found legitimate? What we can verify
Found operates as a telehealth prescriber: a licensed clinician reviews an intake and issues a prescription, and a pharmacy fills it. That is the lawful model, and it is the same model every provider on this site uses; the questions that separate a legitimate operation from a risky one are whether the price is published before intake, whether the pharmacy is named, whether the prescription documents a clinical reason for a compounded product, and whether the company answers questions in writing. Its prices are recorded from a dated third-party source and have not yet been checked against its own pages. It does not publicly name its dispensing pharmacy, so a patient cannot verify the license without asking. We have no evidence of a scam, and we do not use the word for any provider that prescribes on a valid prescription and ships from a licensed pharmacy; LegitScript certification, BBB profiles and state-board actions are not yet captured in our data and are listed as checks a patient can make.
Found complaints and reputation
We have not yet analyzed public reviews of Found for complaint patterns; the reputation index explains the method (shipping, billing and refund, provider access, support, and dosing-instruction complaints as shares of recent reviews). Until it is run, the useful checks are Trustpilot and the Better Business Bureau for volume and recency, and Reddit threads for the specific failure modes patients describe: shipments that arrive warm, charges after cancellation, clinicians who do not answer, and dosing sheets that do not match the vial.
Fees, HSA/FSA and promotions
Introductory pricing recorded: $149 for the first 1 month of tirzepatide. We record introductory prices as data and do not publish promotional codes. HSA/FSA eligibility is not captured; most telehealth GLP-1 programs can issue itemized receipts for FSA/HSA reimbursement, but eligibility of compounded medication depends on the plan administrator. The consultation is included in the price.
Consultation, labs, refills and shipping
Consultation type: asynchronous. Lab requirements are not captured; many providers accept recent labs and some require none for compounded GLP-1s, while brand-name and insurance-first programs more often require them. Refill process is not captured; ask how a dose increase is requested, how many days before the next dose a refill ships, and whether a new visit is required. Shipping is billed separately.
Alternatives to Found
Alternatives worth comparing: NexLife has the highest value score for tirzepatide (91) at $1,668 for twelve months; SnagRx has the lowest twelve-month total ($1,428, verified); Remedy Meds is priced closest to Found ($4,668 for twelve months); Willow is priced closest to Found ($4,788 for twelve months). Side-by-side: Found vs NexLife.
Update history
No price changes or corrections have been logged for Found since tracking began on August 25, 2026. Any future change appears on the price history page with the date, old figure, new figure and source.
How we verified this
Found's site advertises compounded GLP-1 treatment from $99 plus membership/program options from $49; its tirzepatide store page supports a $149 first-month offer, while the $359 renewal figure rests on a third-party directory. Found says it works with licensed 503A pharmacies without naming them. Verified against the provider's own pages on 2026-09-04 (first-party verification pass).